Earnings Data
Report Date
Oct 29, 2026TBA (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.85Last Year’s EPS
-3.43Same Quarter Last Year
Moderate Buy
Based on 6 Analysts Ratings
DE:25K0 Q2 2026 Earnings Report
DE:25K0 Upcoming Earnings
Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
DE:25K0 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:25K0 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 13, 2026 | €1.72 | €1.63 | -5.23% |
May 14, 2026 | €7.25 | €7.45 | +2.76% |
Feb 12, 2026 | €5.15 | €6.10 | +18.45% |
Nov 03, 2025 | €4.96 | €4.98 | +0.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Karyopharm Therapeutics (DE:25K0) report earnings?
Karyopharm Therapeutics (DE:25K0) is schdueled to report earning on Oct 29, 2026, TBA (Confirmed).
What is Karyopharm Therapeutics (DE:25K0) earnings time?
Karyopharm Therapeutics (DE:25K0) earnings time is at Oct 29, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Karyopharm Therapeutics stock?
The P/E ratio of Karyopharm Therapeutics is N/A.
What is DE:25K0 EPS forecast?
DE:25K0 EPS forecast for the fiscal quarter 2026 (Q3) is -0.85.